Compositions and methods comprising thyronamine derivatives and analogs are useful to treat shock, including but not limited to, haemorrhagic (hypovolemic) shock, cardiogenic shock, neurogenic shock, and septic shock in a mammalian subject and to reduce blood loss in a mammalian subject.